Under construction – not a live service
Sign in
Taking people in FranceNo phase

Measuring walking patterns and brain scan lesions in multiple sclerosis

Studies whether a smartphone-based device can assess walking in adults with multiple sclerosis.

Plain-language title generated from the registry record
Registry title: Common and Specific Information From Neuroimaging and Smartphone

Key facts

Where
Nantes, FranceSee the site

Where in France

  • Nantes University HospitalNantes, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Nantes University Hospital
Trial code
NCT05482906
Record updated
13 March 2026
Original description
Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).Read full original descriptionShow less

Individual Gait Pattern and MRI Lesion Load to Quantify Gait Impairment in MS: A Cross Sectional Study.

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).

Inclusion: Diagnosis of MS based on McDonald criteria (including Relapsing-remitting and progressive MS); Over 18 years old /age greater than 18 years; Patients followed at Nantes university hospital or Rennes university hospital; Last known EDSS before inclusion ranging from 0 to 6 inclusive/EDSS of 0 to 6 inclusive, prior inclusion; No relapse within 3 months; With a Medullar MRI planed as part as usual care; MRI scan can be performed within a maximum of 4 months after or before the walking test; Affiliated person or beneficiary of a social security scheme.

Exclusion: Bilateral aid needed to walk; Women who are pregnant; Patient having expressed their opposition; Patient under guardianship or security measure.

ClinicalTrials.gov NCT05482906